Integrated and automated high-throughput purification of libraries on microscale.

Analytical chemistry automation High-throughput purification Laboratory automation Library purification Microscale libraries

Journal

SLAS technology
ISSN: 2472-6311
Titre abrégé: SLAS Technol
Pays: United States
ID NLM: 101697564

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 07 03 2022
revised: 04 08 2022
accepted: 21 08 2022
pubmed: 27 8 2022
medline: 15 12 2022
entrez: 26 8 2022
Statut: ppublish

Résumé

We herein report the development of an automation platform for rapid purification and quantification of chemical libraries including reformatting of chemical matter to 10 mM DMSO stock solutions. This fully integrated workflow features tailored conditions for preparative reversed-phase (RP) HPLC-MS on microscale based on analytical data, online fraction QC and CAD-based quantification as well as automated reformatting to enable rapid purification of chemical libraries. This automated workflow is entirely solution-based, eliminating the need to weigh or handle solids. This increases process efficiency and creates a link between high-throughput synthesis and profiling of novel chemical matter with respect to biological and physicochemical properties in relevant assays.

Identifiants

pubmed: 36028206
pii: S2472-6303(22)05172-X
doi: 10.1016/j.slast.2022.08.002
pii:
doi:

Substances chimiques

Small Molecule Libraries 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350-360

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Carol Ginsburg-Moraff (C)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA. Electronic address: carol.ginsburg-moraff@novartis.com.

Jonathan Grob (J)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA.

Karl Chin (K)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA.

Grant Eastman (G)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA.

Sandra Wildhaber (S)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Mark Bayliss (M)

Virscidian Inc., Cary, NC 27511, USA.

Heinrich M Mues (HM)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Marco Palmieri (M)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Jennifer Poirier (J)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA.

Marcel Reck (M)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Alexandre Luneau (A)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Stephane Rodde (S)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

John Reilly (J)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Trixie Wagner (T)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

Cara E Brocklehurst (CE)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

René Wyler (R)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland.

David Dunstan (D)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Cambridge, MA 02139, USA. Electronic address: david.dunstan@novartis.com.

Alexander N Marziale (AN)

Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Novartis Pharma AG., Fabrikstrasse 1, Basel 4056, Switzerland. Electronic address: alexander.marziale@gmx.de.

Articles similaires

Humans Chondrocytes Osteoarthritis Matrix Metalloproteinase 13 Drug Discovery
Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2
Humans Biomarkers Machine Learning Cardiovascular Diseases Male
Cinnamomum aromaticum China Chromatography, High Pressure Liquid Ecosystem Climate Change

Classifications MeSH